Processa Pharmaceuticals, Inc.·4/A

Feb 18, 5:59 PM ET

Yorke Justin W 4/A

4/A · Processa Pharmaceuticals, Inc. · Filed Feb 18, 2025

Insider Transaction Report

Form 4/AAmended
Period: 2025-01-27
Transactions
  • Award

    Warrants

    2025-01-29+12,40012,400 total(indirect: By Trust)
    Exercise: $0.65From: 2025-01-29Exp: 2030-01-29Common Stock (12,400 underlying)
  • Award

    Warrants

    2025-01-29+6,2006,200 total(indirect: By Trust)
    Exercise: $0.65From: 2025-01-29Exp: 2030-01-29Common Stock (6,200 underlying)
Holdings
  • Common Stock

    (indirect: By LLC)
    31,232
  • Common Stock

    3,737
  • Common Stock

    (indirect: By Trust)
    12,400

Documents

1 file
  • 4
    form4.xml